Spero Therapeutics, Inc. Increase (Decrease) in Other Receivables
Spero Therapeutics, Inc. (SPRO) reported Increase (Decrease) in Other Receivables of -$3.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2026-08-12
- Spero Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2026-06-30 was -$19.00K, a 101.06% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2026-03-31 was $16.00K.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2025-12-31 was -$1.56M, a 501.80% decline year-over-year.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2025-09-30 was -$869.00K.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2025 was -$3.06M, a 298.51% decline from fiscal 2024.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2024 was $1.54M, a 234.06% increase from fiscal 2023.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2023 was $461.00K.
- Spero Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2022 was -$1.55M.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 3 month as first filed | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 6 month as first filed | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 9 month as first filed | Increase (Decrease) in Other Receivables 12 month | Increase (Decrease) in Other Receivables 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$3.00K 10-Q · filed 2026-08-12 | -$1.57M derived: sum of 3 quarters · filed 2026-08-12 | -$2.44M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $16.00K 10-Q · filed 2026-05-13 | -$1.55M derived: sum of 2 quarters · filed 2026-05-13 | -$2.42M derived: sum of 3 quarters · filed 2026-05-13 | -$624.00K derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | -$1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$2.43M derived: sum of 2 quarters · filed 2026-03-26 | -$640.00K derived: sum of 3 quarters · filed 2026-08-12 | -$3.06M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | -$869.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $923.00K derived: sum of 2 quarters · filed 2026-08-12 | -$1.49M 10-Q · filed 2025-11-13 | -$1.10M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$625.00K 10-Q · filed 2026-08-12 | -$236.00K derived: sum of 3 quarters · filed 2026-08-12 | -$2.27M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | -$2.42M 10-Q · filed 2026-05-13 | -$2.03M derived: sum of 2 quarters · filed 2026-05-13 | -$4.07M derived: sum of 3 quarters · filed 2026-05-13 | -$4.35M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $389.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$1.65M derived: sum of 2 quarters · filed 2026-03-26 | -$1.93M derived: sum of 3 quarters · filed 2026-03-26 | $1.54M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | -$2.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.32M derived: sum of 2 quarters · filed 2025-11-13 | $1.15M 10-Q · filed 2025-11-13 | -$293.00K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $3.19M 10-Q · filed 2025-08-12 | $1.75M derived: sum of 3 quarters · filed 2025-08-12 | $2.65M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $3.47M 10-Q · filed 2025-05-13 | $2.03M derived: sum of 2 quarters · filed 2025-05-13 | $2.93M derived: sum of 3 quarters · filed 2025-05-13 | $3.15M derived: sum of 4 quarters · filed 2025-05-13 | ||||
| 2023-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$543.00K derived: sum of 2 quarters · filed 2025-03-27 | -$320.00K derived: sum of 3 quarters · filed 2025-03-27 | $461.00K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $901.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.12M derived: sum of 2 quarters · filed 2024-11-14 | $1.91M 10-Q · filed 2024-11-14 | $2.04M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $1.00M 10-Q · filed 2024-08-05 | $1.14M derived: sum of 3 quarters · filed 2024-08-05 | $511.00K derived: sum of 4 quarters · filed 2024-08-05 | ||||
| 2023-03-31 | $781.00K 10-Q · filed 2024-05-15 | $912.00K derived: sum of 2 quarters · filed 2024-05-15 | $288.00K derived: sum of 3 quarters · filed 2024-05-15 | -$105.00K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | -$493.00K derived: sum of 2 quarters · filed 2024-03-13 | -$886.00K derived: sum of 3 quarters · filed 2024-03-13 | -$1.55M 10-K · filed 2024-03-13 | -$1.20M 10-K · filed 2023-03-30 | |||
| 2022-09-30 | -$624.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.02M derived: sum of 2 quarters · filed 2023-11-13 | -$1.68M 10-Q · filed 2023-11-13 | -$1.37M 10-Q · filed 2022-11-14 | -$1.64M derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | -$393.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.05M 10-Q · filed 2023-08-10 | -$721.00K 10-Q · filed 2022-08-10 | -$1.02M derived: sum of 3 quarters · filed 2023-08-10 | -$625.00K derived: sum of 4 quarters · filed 2023-08-10 | |||
| 2022-03-31 | -$661.00K 10-Q · filed 2023-05-11 | -$660.00K 10-Q · filed 2022-05-16 | -$623.00K derived: sum of 2 quarters · filed 2023-05-11 | -$232.00K derived: sum of 3 quarters · filed 2023-05-11 | -$6.93M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $429.00K derived: sum of 2 quarters · filed 2023-03-30 | -$6.27M derived: sum of 3 quarters · filed 2023-03-30 | -$3.05M 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.31M derived: sum of 2 quarters · filed 2022-11-14 | -$3.09M 10-Q · filed 2022-11-14 | -$4.83M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$6.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$3.48M 10-Q · filed 2022-08-10 | -$5.22M derived: sum of 3 quarters · filed 2022-08-10 | -$2.18M derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $3.22M 10-Q · filed 2022-05-16 | $1.47M derived: sum of 2 quarters · filed 2022-05-16 | $4.51M derived: sum of 3 quarters · filed 2022-05-16 | $5.82M derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | -$1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.30M derived: sum of 2 quarters · filed 2022-03-31 | $2.61M derived: sum of 3 quarters · filed 2022-03-31 | -$2.43M 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $3.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $4.35M derived: sum of 2 quarters · filed 2021-11-10 | -$686.00K 10-Q · filed 2021-11-10 | $2.06M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$3.73M 10-Q · filed 2021-08-05 | -$980.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.96M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$5.04M 10-Q · filed 2021-05-06 | -$2.29M derived: sum of 2 quarters · filed 2021-05-06 | $651.00K derived: sum of 3 quarters · filed 2021-05-06 | $2.27M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $2.75M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.69M derived: sum of 2 quarters · filed 2021-03-11 | $7.30M derived: sum of 3 quarters · filed 2021-03-11 | $7.38M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $2.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.56M derived: sum of 2 quarters · filed 2020-11-05 | $4.64M 10-Q · filed 2020-11-05 | $4.68M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $1.70M 10-Q · filed 2020-08-06 | $1.74M derived: sum of 3 quarters · filed 2020-08-06 | $1.28M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | $80.00K 10-Q · filed 2020-05-08 | $124.00K derived: sum of 2 quarters · filed 2020-05-08 | -$338.00K derived: sum of 3 quarters · filed 2020-05-08 | -$763.00K derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$418.00K derived: sum of 2 quarters · filed 2020-03-16 | -$843.00K derived: sum of 3 quarters · filed 2020-03-16 | -$635.00K 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | -$462.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | -$887.00K derived: sum of 2 quarters · filed 2019-11-04 | -$679.00K 10-Q · filed 2019-11-04 | -$205.00K derived: sum of 4 quarters · filed 2019-11-04 | ||||
| 2018-06-30 | -$425.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$217.00K 10-Q · filed 2019-08-08 | $257.00K derived: sum of 3 quarters · filed 2019-08-08 | $566.00K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $208.00K 10-Q · filed 2019-05-09 | $682.00K derived: sum of 2 quarters · filed 2019-05-09 | $991.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.10M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $474.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $783.00K derived: sum of 2 quarters · filed 2019-03-14 | $897.00K derived: sum of 3 quarters · filed 2019-03-14 | $707.00K 10-K · filed 2019-03-14 | ||||
| 2017-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $423.00K derived: sum of 2 quarters · filed 2018-11-08 | $233.00K 10-Q · filed 2018-11-08 | $537.00K derived: sum of 4 quarters · filed 2019-03-14 | ||||
| 2017-06-30 | $114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$76.00K 10-Q · filed 2018-08-09 | $228.00K derived: sum of 3 quarters · filed 2019-03-14 | |||||
| 2017-03-31 | -$190.00K 10-Q · filed 2018-05-10 | $114.00K derived: sum of 2 quarters · filed 2019-03-14 | ||||||
| 2016-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $294.00K 10-K · filed 2019-03-14 | ||||||
| 2016-09-30 | -$10.00K 10-Q · filed 2017-12-14 | |||||||
| 2015-12-31 | $10.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |